1 / 42

Risk For MI After Arthroplasty

Present by R2 Choopong Luansritisakul R2 Jittrawan Attawattanakul Supervise by Assoc.Prof . Sirilak Suksompong. Risk For MI After Arthroplasty. A 81 year-old man Admit for Elective total hip replacement Underlying disease : HT on Atenolol (50) 1x1

adonia
Télécharger la présentation

Risk For MI After Arthroplasty

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Present by R2 ChoopongLuansritisakul R2 JittrawanAttawattanakul Supervise by Assoc.Prof. SirilakSuksompong Risk For MI After Arthroplasty

  2. A 81 year-old man • Admit for Elective total hip replacement • Underlying disease : HT on Atenolol (50) 1x1 DLP on Simvastatin (20) 1x1 Old CVA 4year ago (full recovery) Previous MI 11 months ago • Choice of anesthesia : GA with ETT • Intraoperative : no complication • POD 7 : typical angina , ECG CK-MB 2.7 (0-3ng/ml), Trop-T 1.78(0-0.2ng/ml) Imp NSTEMI

  3. Postoperative MI ?

  4. Acute Myocardial Infarction • Definition • Detection of  and/or  of cardiac biomarker values (preferably cardiac troponin) with > value above the 99th percentile upper reference limit and with > one of the following : Circulation, published online August 24,2012; 2012 American Heart Association,Inc.

  5. Symptoms of ischemia • New or presumed new significant ST-T changes or new LBBB • Development of pathological Q waves in ECG • Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality • Identification of an intracoronary thrombus by angiography or autopsy Circulation, published online August 24,2012; 2012 American Heart Association,Inc.

  6. LBBB

  7. Postoperative Myocardial Infarction • Often recognized late (postoperative day 3 - 5), resulting in high (30% - 70%) mortality

  8. Morbidity and Mortality Incidence From Anesthesiologist records in last year

  9. 9 case

  10. Perioperative MI

  11. Myocardial Infarction VS Total Hip or Knee Replacement

  12. Limitation such as • small sample sizes • lack of matched control • only focused on short-term • no analysis for medication

  13. Strengths • The nationwide population-based design • Large sample size • Information on matched controls • Completeness of follow-up

  14. Nationwide matched control retrospective cohort study • The Danish national registries

  15. Inclusion criteria • Patients who underwent a primary THR or TKR surgery • January,1998 to December, 2007 • Age 18 years or older

  16. Exclusion criteria • Prior AMI within 6 weeks before

  17. 95,664 Patients 437 patients excluded THR group (n=66,524) Control group (n=200,001) TKR group (n=28,703) Control group (n=86,164) Thromboprophylaxis Thromboprophylaxis • Followed up until - Death • Migration • Revision THR or TKR • End of study period • Acute myocardial infarction

  18. Incidence of acute myocardial infarction • Potential risk factors • Age • Sex • History of AMI, heart failure, cerebrovascular disease • Drug dispensing within 6 months

  19. Baseline Characteristics of patients Undergoing THR and Matched control

  20. Drug use within previous 6 mth (%)

  21. 2 weeks

  22. 6 weeks

  23. Effect Modifiers of AMI risk after THR or TKR vs Matched controls Adjusted HR (6-wk risk for AMI)

  24. Marrow Embolization Antithrombotic Agents

  25. Limitations • Lack of information on other risk factors for AMI • smoking, blood pressure, biochemical variables, and BMI • No information on inpatient anticoagulant use • No information about GA or RA

  26. GA vs RA • General anesthesia vs Regional anesthesia showed a trend toward only 1.4 fold increase risk of AMI Anesthesia for hip fracture surgery in adults (Review) 2004 The Cochrane Collaboration

  27. Increase risk of AMI during the first 2 weeks after arthroplasty • AMI within 1 year should be contraindication for undergoing elective THR surgery

  28. Prophylactic therapy •  Adrenergic Blockers • Statins • Calcium channel Blockers • 2 Agonists • Aspirin

  29. Prophylactic therapy •  Adrenergic Blockers • Long term should not be discontinued • No study has compared prophylactic B-Blockade with short term

  30. Prophylactic therapy •  Adrenergic Blockers • Statins • Abrupt withdrawal cause plaque destabilization • Reduced perioperative and long term cardiac complication • Large randomized controlled trials are still needed

  31. Perioperative Management • Correct tachycardia, hypertension, hypotension, and pain • Tight hemodynamic monitoring • Blood transfusion in patients with CAD and Hb<10 • Coronary intervention and antithrombotic therapy

  32. Take Home Messages • New definition of AMI • THR and TKR patients increased risk of AMI during the first 2 weeks after surgery • Elective THR and TKR should be contraindicated in patients with previous MI in last 1 year before • Management for decrease risk of postoperative MI are necessary

  33. THANK YOU

More Related